September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
Groundbreaking new CAR T cell trial opens for patients with breast cancer that has spread to the brain
October 30, 2018 | Letisia Marquez
A new City of Hope chimeric antigen receptor (CAR) T cell trial – the first to focus on HER2-postive breast cancer patients with brain metastases – is now enrolling potential participants.
Parker Institute for Cancer Immunotherapy Welcomes Stephen J. Forman, M.D.
September 27, 2018 | Letisia Marquez
City of Hope’s Stephen J. Forman, M.D., is now an official member of the Parker Institute for Cancer Immunotherapy.
City of Hope's Stephen J. Forman Joins Parker Institute for Cancer Immunotherapy
July 16, 2018 | Letisia Marquez
City of Hope’s CAR T research and treatment team is now an official member of the Parker Institute for Cancer Immunotherapy.
Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program
April 2, 2018 | Wayne Lewis
Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.
Meet Our CAR T Team: Christine Brown, Ph.D.
January 26, 2018 | Abe Rosenberg
Christine Brown, Ph.D., co-leads the T Cell Therapeutics Research Laboratory, along with Stephen J. Forman, M.D., which to date has treated more than 100 patients in seven clinical trials, with aggressive goals of opening four new clinical studies within the year.
City of Hope researchers find CAR T cell therapy effective in treatment of glioblastoma
July 17, 2017 | Denise Heady
City of Hope researchers have found that using CAR T therapy, a type of immunotherapy, can be effective in the treatment of glioblastoma — one of the most aggressive brain tumors known to medicine.
CAR T cells: ‘Soldiers of the Immune System’
July 10, 2017 | Stephanie Smith
T cells were genetically modified in a lab by City of Hope researchers and trained to target specific receptors on patients’ brain tumors - part of an emerging approach to cancer care called immunotherapy.